RealTime Laboratories Released New Mycotoxin Test Panel
The expanded diagnostic panel offers an increased capability to detect 31 different mycotoxin markers.
Updated on Sept. 22, 2026 in Allergies
Live Poll
Do you trust that new medical diagnostic tests reliably improve patient health outcomes?
RealTime Laboratories has introduced an updated urinary mycotoxin test panel that identifies 31 distinct markers. This release expands the diagnostic scope by adding 16 new mycotoxins compared to previous testing versions.
Why it matters
The test is designed to provide both practitioners and patients with a more comprehensive overview of potential mold exposure. By increasing the number of detected markers, the panel aims to enhance the clinical understanding of mycotoxin presence in the body.
The updated panel tracks 31 total mycotoxin markers, representing an increase of 16 compared to prior versions. Analysis is conducted using liquid chromatography-tandem mass spectrometry paired with proprietary hydrolysis processing technology.
The players
RealTime Laboratories
This is a diagnostic company headquartered in the United States that specializes in the identification of environmental toxins.
The details
The testing process utilizes liquid chromatography-tandem mass spectrometry to ensure accurate detection of contaminants. Proprietary hydrolysis processing technology is integrated into the workflow to facilitate a more comprehensive screening of urinary samples.
Timeline
September 22, 2026: RealTime Laboratories launched the new mycotoxin test panel.
The Big Picture
The adoption of liquid chromatography-tandem mass spectrometry reflects a broader industry movement toward higher sensitivity in diagnostic testing. This panel follows the standard industry trajectory of integrating advanced mass spectrometry techniques to improve diagnostic depth.
Patients and practitioners now have access to a broader diagnostic tool that may identify mold-related issues previously missed by older tests. This expanded panel could lead to more tailored health strategies for individuals concerned about environmental exposures.
The takeaway
Advancements in mass spectrometry are making it easier to screen for a wider variety of environmental contaminants through non-invasive testing. Clinicians should review the updated list of markers to determine if this panel provides better utility for specific patient symptom profiles.
Further reading
Learn more about advancements in diagnostic testing and sensitivities in the Allergies section.
Live Poll
Do you trust that new medical diagnostic tests reliably improve patient health outcomes?
